Untargeted metabolomics yields insight into ALS disease mechanisms

OBJECTIVE: To identify dysregulated metabolic pathways in amyotrophic lateral sclerosis (ALS) versus control participants through untargeted metabolomics. METHODS: Untargeted metabolomics was performed on plasma from ALS participants (n=125) around 6.8 months after diagnosis and healthy controls (n=...

Descripción completa

Detalles Bibliográficos
Autores principales: Goutman, Stephen A, Boss, Jonathan, Guo, Kai, Alakwaa, Fadhl M, Patterson, Adam, Kim, Sehee, Savelieff, Masha Georges, Hur, Junguk, Feldman, Eva L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neuromuscular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677469/
https://www.ncbi.nlm.nih.gov/pubmed/32928939
http://dx.doi.org/10.1136/jnnp-2020-323611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677469/
https://www.ncbi.nlm.nih.gov/pubmed/32928939
http://dx.doi.org/10.1136/jnnp-2020-323611

Ejemplares similares